Stem cell programme expands
Six months after Namibia’s first autologous stem cell transplant, the national programme has evolved from a medical milestone into a growing treatment service.
For many patients, this marks a significant step forward, as they no longer need to travel to South Africa for this therapy.
However, the programme’s future depends heavily on a stable and reliable blood supply.
The service was launched in November 2025 through a collaboration between six healthcare institutions. Since then, four stem cell transplants have been performed, while two additional patients are currently undergoing treatment. According to those involved, treatment in Namibia costs more than 35% less than in South Africa, where similar procedures can exceed N$800 000.
Clinical haematologist and transplant physician Dr Kudakwashe Simba described the progress as rapid, noting that a sixth patient is already receiving treatment. He emphasised the importance of allowing families to access care locally, without having to disrupt their lives to seek treatment abroad.
Blood needed
Experts highlight that stem cell transplants are among the most blood-intensive treatments in modern medicine. Patients first undergo high-dose chemotherapy, which temporarily suppresses blood production. Until the transplanted stem cells restore normal function, many rely heavily on donated blood.
According to the Blood Transfusion Service of Namibia (NamBTS), demand has already increased significantly. While oncology patients previously accounted for around 16% of national blood product use, their share has now risen to between 20% and 23%. This increase is largely driven by blood-related cancers such as leukaemia, lymphoma, and multiple myeloma.
Dr Carla van Zyl of NamBTS said this reflects the expansion of specialised cancer treatment in the country. As Namibia’s capacity to treat complex conditions grows, so too does the demand for blood products. Currently, the country’s blood reserves last between five and eight days, depending on demand, making a consistent donor base essential.
Further expansion of the programme is already planned. In future, transplants using donor cells will be introduced, while greater integration with public hospitals is expected to improve access. Health officials are therefore urging the public to donate blood regularly, noting that every donation strengthens national reserves and directly supports life-saving treatment.
